Literature DB >> 8255207

A mouse model for varicella-zoster virus latency.

Z Wroblewska1, T Valyi-Nagy, J Otte, A Dillner, A Jackson, D P Sole, N W Fraser.   

Abstract

Following primary infection with varicella-zoster virus (VZV), the virus establishes a latent infection in humans. The molecular pathogenesis of VZV latency is not well understood, mainly due to the lack of an adequate animal model. We report here that we have developed a mouse model for VZV infection that involves corneal inoculation of mice. Although infected animals showed no signs of disease, most of the animals could not eliminate the virus early after infection. By PCR, we demonstrated that at 33 days post-infection (p.i.), viral DNA was still present in more than 60% of the animals (14/21). VZV DNA was most frequently detected in the trigeminal ganglia (7/14) followed by the brain stem (10/21), kidneys (4/21), spleen (3/20), liver (2/21) and brain (1/21). By in situ hybridization, a few cells positive for VZV mRNA were detected in the trigeminal ganglia, brain stem, cerebellum and spleen of a small number of the infected animals as late as 33 days p.i. No viral proteins were detected at the site of inoculation or in any other tissue by immunostaining. Our results suggest that VZV spreads in mice by both viraemia and axonal transport and establishes a non-productive (latent) infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8255207     DOI: 10.1006/mpat.1993.1064

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  17 in total

1.  Reactivation of Simian Varicella Virus in Rhesus Macaques after CD4 T Cell Depletion.

Authors:  Vicki Traina-Dorge; Brent E Palmer; Colin Coleman; Meredith Hunter; Amy Frieman; Anah Gilmore; Karen Altrock; Lara Doyle-Meyers; Maria A Nagel; Ravi Mahalingam
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

2.  Postentry events are responsible for restriction of productive varicella-zoster virus infection in Chinese hamster ovary cells.

Authors:  Renée L Finnen; Kara R Mizokami; Bruce W Banfield; Guang-Yun Cai; Scott A Simpson; Lewis I Pizer; Myron J Levin
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

Review 3.  Review: The neurobiology of varicella zoster virus infection.

Authors:  D Gilden; R Mahalingam; M A Nagel; S Pugazhenthi; R J Cohrs
Journal:  Neuropathol Appl Neurobiol       Date:  2011-08       Impact factor: 8.090

4.  Simian varicella virus pathogenesis.

Authors:  Ravi Mahalingam; Ilhem Messaoudi; Don Gilden
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

5.  Phenotypic and genetic characterization of varicella-zoster virus mutants resistant to acyclovir, brivudine and/or foscarnet.

Authors:  Karoline Bleymehl; Jindrich Cinatl; Jonas Schmidt-Chanasit
Journal:  Med Microbiol Immunol       Date:  2011-03-04       Impact factor: 3.402

Review 6.  Rodent models of varicella-zoster virus neurotropism.

Authors:  Jeffrey I Cohen
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

Review 7.  A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation.

Authors:  Peter G E Kennedy; Joel Rovnak; Hussain Badani; Randall J Cohrs
Journal:  J Gen Virol       Date:  2015-03-20       Impact factor: 3.891

8.  Immune Responses to Varicella-Zoster Virus Glycoprotein E Formulated with Poly(Lactic-co-Glycolic Acid) Nanoparticles and Nucleic Acid Adjuvants in Mice.

Authors:  Yunfei Wang; Jialong Qi; Han Cao; Cunbao Liu
Journal:  Virol Sin       Date:  2020-08-05       Impact factor: 4.327

Review 9.  Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency.

Authors:  Niklaus H Mueller; Donald H Gilden; Randall J Cohrs; Ravi Mahalingam; Maria A Nagel
Journal:  Neurol Clin       Date:  2008-08       Impact factor: 3.806

10.  CD4 T cell immunity is critical for the control of simian varicella virus infection in a nonhuman primate model of VZV infection.

Authors:  Kristen Haberthur; Flora Engelmann; Byng Park; Alex Barron; Alfred Legasse; Jesse Dewane; Miranda Fischer; Amelia Kerns; Monica Brown; Ilhem Messaoudi
Journal:  PLoS Pathog       Date:  2011-11-10       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.